Aspiriant LLC’s iShares S&P Small-Cap 600 Value ETF IJS Stock Holding History

Aspiriant LLC’s Portfolio IJS Stock Details IJS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,620	Closed	-$339K	–	288
2023 Q1	$339K	Buy	+3,620	New	+$354K	0.02%	206
2021 Q3	–	Sell	-4,010	Closed	-$423K	–	238
2021 Q2	$423K	Buy	+4,010	New	+$419K	0.02%	168

Other funds holding IJS

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

RFC

Regions Financial Corp Birmingham, Alabama $16.8B AUM 26.68% 1-Year Est. Return

M&T Bank Buffalo, New York $34.1B AUM 29.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $10.3B AUM 25.54% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Aspiriant LLC's IJS Position: Q2 2023 in Review

Aspiriant LLC sold out of iShares S&P Small-Cap 600 Value ETF (IJS) in Q2 2023, closing a stake of 3,620 shares — an estimated $339K sold.

Aspiriant LLC first reported a position in IJS in Q2 2021 and held it in 2 quarters. The position peaked at $423K in Q2 2021. 735 funds tracked by Wall St. Rank hold IJS as of Q2 2023.

Aspiriant LLC reported no remaining iShares S&P Small-Cap 600 Value ETF position as of Q2 2023 after selling out during the quarter.
Aspiriant LLC sold 3,620 iShares S&P Small-Cap 600 Value ETF shares in Q2 2023, an estimated $339K.
Aspiriant LLC first reported a position in iShares S&P Small-Cap 600 Value ETF in Q2 2021 and held it in 2 quarters.
Aspiriant LLC's iShares S&P Small-Cap 600 Value ETF position peaked at $423K in Q2 2021.
735 funds tracked by Wall St. Rank held iShares S&P Small-Cap 600 Value ETF as of Q2 2023.

Based on Aspiriant LLC's 13F filing for Q2 2023, filed 19 Jul 2023.